Functionally, we first demonstrated the tumor-suppressive role of miR-516a-5p in HCC both in vitro and in vivo and identified PBX3 as a novel target of miR-516a-5p via its binding to the 3′-UTR of the PBX3 mRNA in HCC cells. Here, PBX3 is linked to hepatocellular carcinoma.